Volgen
Zirong Chen
Zirong Chen
OncoNano Medicine
Geverifieerd e-mailadres voor onconanomed.com
Titel
Geciteerd door
Geciteerd door
Jaar
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth
Z Chen, JL Li, S Lin, C Cao, NT Gimbrone, R Yang, DA Fu, MB Carper, ...
The Journal of clinical investigation 126 (6), 2267-2279, 2016
1972016
DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia
S Lin, L Tian, H Shen, Y Gu, JL Li, Z Chen, X Sun, M James You, L Wu
Oncogene 32 (40), 4845-4853, 2013
1002013
Recent insights into the biological activities and drug delivery systems of tanshinones
Y Cai, W Zhang, Z Chen, Z Shi, C He, M Chen
International Journal of Nanomedicine, 121-130, 2016
972016
Aberrantly activated AREG–EGFR signaling is required for the growth and survival of CRTC1–MAML2 fusion-positive mucoepidermoid carcinoma cells
Z Chen, J Chen, Y Gu, C Hu, JL Li, S Lin, H Shen, C Cao, R Gao, J Li, ...
Oncogene 33 (29), 3869-3877, 2014
902014
Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion
Y Gu, S Lin, JL Li, H Nakagawa, Z Chen, B Jin, L Tian, DA Ucar, H Shen, ...
Oncogene 31 (4), 469-479, 2012
892012
A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets
R Gao, C Cao, M Zhang, MC Lopez, Y Yan, Z Chen, Y Mitani, L Zhang, ...
Oncotarget 5 (24), 12528, 2014
532014
Brief report: Blockade of Notch signaling in muscle stem cells causes muscular dystrophic phenotype and impaired muscle regeneration
S Lin, H Shen, B Jin, Y Gu, Z Chen, C Cao, C Hu, C Keller, WS Pear, L Wu
Stem Cells 31 (4), 823-828, 2013
482013
CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells
Z Chen, S Lin, JL Li, W Ni, R Guo, J Lu, FJ Kaye, L Wu
Oncogene 37 (14), 1885-1895, 2018
462018
Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer
C Cao, R Gao, M Zhang, AL Amelio, M Fallahi, Z Chen, Y Gu, C Hu, ...
Journal of the National Cancer Institute 107 (1), dju358, 2015
452015
The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-κB signaling and cell survival
B Jin, H Shen, S Lin, JL Li, Z Chen, JD Griffin, L Wu
Journal of biological chemistry 285 (19), 14356-14365, 2010
432010
The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma
Z Chen, W Ni, JL Li, S Lin, X Zhou, Y Sun, JW Li, ME Leon, MD Hurtado, ...
JCI insight 6 (7), 2021
422021
Proteomic and Functional Analyses Reveal the Role of Chromatin Reader SFMBT1 in Regulating Epigenetic Silencing and the Myogenic Gene Program*[S]
S Lin, H Shen, JL Li, S Tang, Y Gu, Z Chen, C Hu, JC Rice, J Lu, L Wu
Journal of Biological Chemistry 288 (9), 6238-6247, 2013
402013
Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells
J Chen, JL Li, Z Chen, JD Griffin, L Wu
BMC cancer 15, 1-13, 2015
362015
Role of INSL4 signaling in sustaining the growth and viability of LKB1-inactivated lung cancer
R Yang, SW Li, Z Chen, X Zhou, W Ni, DA Fu, J Lu, FJ Kaye, L Wu
JNCI: Journal of the National Cancer Institute 111 (7), 664-674, 2019
272019
Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma
W Ni, Z Chen, X Zhou, R Yang, M Yu, J Lu, FJ Kaye, L Wu
Signal Transduction and Targeted Therapy 6 (1), 27, 2021
142021
DNA methyltransferase inhibitor CDA-II inhibits myogenic differentiation
Z Chen, G Jin, S Lin, X Lin, Y Gu, Y Zhu, C Hu, Q Zhang, L Wu, H Shen
Biochemical and biophysical research communications 422 (3), 522-526, 2012
112012
Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation
X Zhou, JW Li, Z Chen, W Ni, X Li, R Yang, H Shen, J Liu, FJ DeMayo, ...
Elife 10, e66095, 2021
82021
Overexpression of Six1 leads to retardation of myogenic differentiation in C2C12 myoblasts
Z Li, D Deng, H Huang, L Tian, Z Chen, Y Zou, G Jin, J Wang, Q Zhang, ...
Molecular biology reports 40, 217-223, 2013
62013
ONM-501: A polyvalent STING agonist for oncology immunotherapy
S Li, J Wang, J Wilhelm, Q Su, G Bharadwaj, J Miller, W Li, K Torres, ...
Cancer Research 82 (12 Supplement), 4234, 2022
32022
1331 Dual blockade of the EP2 and EP4 PGE2 receptors with TPST-1495 is an optimal approach for drugging the prostaglandin pathway
J Lopez, A Holtz, D Freund, D Burdette, D Wang, R Duboise, S Whiting, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
2*2022
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20